Status:
COMPLETED
Knowledge and Perception of Smoking Risks/Consequences
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cigarette Smoking
Schizophrenia
Eligibility:
All Genders
18-65 years
Brief Summary
This proposed 2-year questionnaire study examines views and attitudes regarding health risks of cigarette smoking, smoking patterns and motivators for cessation in smokers who suffer from schizophreni...
Detailed Description
This proposed 2-year questionnaire study examines views and attitudes regarding health risks of cigarette smoking, smoking patterns and motivators for cessation in smokers who suffer from schizophreni...
Eligibility Criteria
Inclusion
- Males and females between 18-65 years
- Minimum of 5 cigarettes daily.
- Expired CO measurement of \> 8 ppm to confirm cigarette smoking
- For the schizophrenia group, must have a DSM-IV diagnosis of schizophrenia or schizoaffective disorder.
Exclusion
- For the normal control group, must be free from Axis I psychotic disorder. (other psychiatric comorbidity will not be excluded)
- For all subjects, anyone actively trying to quit smoking at the time of the interview.
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00686101
Start Date
December 1 2007
End Date
June 1 2009
Last Update
November 4 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute on Drug Abuse (Johns Hopkins Bayview Campus)
Baltimore, Maryland, United States, 21224
2
Maryland Psychiatric Research Center, University of Maryland School of Medicine
Baltimore, Maryland, United States, 21228